Press releases | WebDisclosure

PRESS RELEASE

published on 10/24/2025 at 07:44, 1 year ago

Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical
Ottobock strengthens investment in NeuroTech company ONWARD Medical, supporting innovative therapies for spinal cord injury. Companies deepen strategic partnership for joint innovation in NeuroTech, NeuroOrthotics, and Exoskeletons

Strategic Partnership Investment Ottobock ONWARD Medical NeuroTech
PRESS RELEASE

published on 10/24/2025 at 07:30, 1 year ago

Circus SE Secures Core Technologies Through Six New Defense Patents
Circus SE secures core defense technologies with six new patents for autonomous AI robot CA-M, enhancing competitive advantage in global defense market

Circus SE Global Market Patents Defense Technologies Autonomous AI Robot
PRESS RELEASE

published on 10/24/2025 at 07:30, 1 year ago

Communiqué de presse : T3 : croissance continue du chiffre d’affaires et du bénéfice
PRESS RELEASE

published on 10/24/2025 at 07:30, 1 year ago

Press release: Q3: continued sales and earnings progress
PRESS RELEASE

published on 10/24/2025 at 07:05, 1 year ago

LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation
LEPAS Fun Test Drive showcases LEPAS's elegant technology through user co-creation for intelligent driving experiences. Events highlight Chery Group's innovative ecosystem vision

Intelligent Driving Chery Group LEPAS Elegant Technology User Co-Creation
PRESS RELEASE

published on 10/24/2025 at 07:00, 1 year ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325

Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE

published on 10/24/2025 at 07:00, 1 year ago

BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery
BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments

BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
REGULATED PRESS RELEASE

published on 10/24/2025 at 07:00, 1 year ago

Safran publie son chiffre d’affaires du 3ème trimestre 2025
Safran publie un chiffre d'affaires en hausse de 18,3% au 3e trimestre 2025 et révise à la hausse ses perspectives annuelles, notamment pour les moteurs LEAP et les activités d'après-vente

Chiffre D'affaires Safran Perspectives Annuelles Moteurs LEAP 3e Trimestre 2025
REGULATED PRESS RELEASE

published on 10/24/2025 at 07:00, 1 year ago

Safran reports third quarter 2025 revenue
Safran reports strong Q3 2025 revenue growth of 18.3% reaching €7,852 million. FY guidance raised with solid organic growth in civil engines aftermarket and record LEAP output

Safran FY Guidance Q3 2025 Revenue Civil Engines Aftermarket LEAP Output
PRESS RELEASE

published on 10/24/2025 at 06:59, 1 year ago

Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA

EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA

Published on 11/05/2026 at 15:20, 3 hours 32 minutes ago

MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 4 hours 21 minutes ago

First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 4 hours 27 minutes ago

Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 4 hours 32 minutes ago

Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 4 hours 37 minutes ago

Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook

View all ACCESSWIRE

Published on 11/05/2026 at 18:30, 22 minutes ago

Dividend Declaration
Published on 11/05/2026 at 18:09, 43 minutes ago

EQS-Adhoc: JOST Werke SE: JOST raises outlook for fiscal year 2026
Published on 11/05/2026 at 18:00, 52 minutes ago

2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026
Published on 11/05/2026 at 18:00, 52 minutes ago

2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of October 31, 2026
Published on 11/05/2026 at 18:00, 52 minutes ago

E-PANGO: Composition du capital au 31 octobre 2026

View all EQS

Published on 11/05/2026 at 18:21, 30 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 30 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 50 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026
Published on 11/05/2026 at 17:50, 1 hour 2 minutes ago

NRJ GROUP - Financial information Q3 2026
Published on 11/05/2026 at 17:50, 1 hour 2 minutes ago

NRJ GROUP - Information financière T3 2026

View all LES ECHOS COMFI WIRE

News